These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35044182)

  • 21. Preclinical Characterization of DPI-4452: A
    Massière F; Wiedemann N; Borrego I; Hoehne A; Osterkamp F; Paschke M; Zboralski D; Schumann A; Bredenbeck A; Brichory F; Attinger A
    J Nucl Med; 2024 May; 65(5):761-767. PubMed ID: 38514083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new peptide ligand for targeting human carbonic anhydrase IX, identified through the phage display technology.
    Askoxylakis V; Garcia-Boy R; Rana S; Krämer S; Hebling U; Mier W; Altmann A; Markert A; Debus J; Haberkorn U
    PLoS One; 2010 Dec; 5(12):e15962. PubMed ID: 21209841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preclinical and pilot clinical evaluation of a small-molecule carbonic anhydrase IX targeting PET tracer in clear cell renal cell carcinoma.
    Zhu W; Li X; Zheng G; Bai C; Ji Z; Zhang H; Xing H; Zhang Y; Huo L
    Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):3116-3125. PubMed ID: 37246998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imaging of carbonic anhydrase IX with an 111In-labeled dual-motif inhibitor.
    Yang X; Minn I; Rowe SP; Banerjee SR; Gorin MA; Brummet M; Lee HS; Koo SM; Sysa-Shah P; Mease RC; Nimmagadda S; Allaf ME; Pomper MG
    Oncotarget; 2015 Oct; 6(32):33733-42. PubMed ID: 26418876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ImmunoPET imaging of renal cell carcinoma with (124)I- and (89)Zr-labeled anti-CAIX monoclonal antibody cG250 in mice.
    Stillebroer AB; Franssen GM; Mulders PF; Oyen WJ; van Dongen GA; Laverman P; Oosterwijk E; Boerman OC
    Cancer Biother Radiopharm; 2013 Sep; 28(7):510-5. PubMed ID: 23697926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [(18)F]VM4-037 MicroPET Imaging and Biodistribution of Two In Vivo CAIX-Expressing Tumor Models.
    Peeters SG; Dubois L; Lieuwes NG; Laan D; Mooijer M; Schuit RC; Vullo D; Supuran CT; Eriksson J; Windhorst AD; Lambin P
    Mol Imaging Biol; 2015 Oct; 17(5):615-9. PubMed ID: 25708744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a Small Molecule Tubulysin B Conjugate for Treatment of Carbonic Anhydrase IX Receptor Expressing Cancers.
    Marks IS; Gardeen SS; Kurdziel SJ; Nicolaou ST; Woods JE; Kularatne SA; Low PS
    Mol Pharm; 2018 Jun; 15(6):2289-2296. PubMed ID: 29715036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic mechanism and efficacy of the antibody-drug conjugate BAY 79-4620 targeting human carbonic anhydrase 9.
    Petrul HM; Schatz CA; Kopitz CC; Adnane L; McCabe TJ; Trail P; Ha S; Chang YS; Voznesensky A; Ranges G; Tamburini PP
    Mol Cancer Ther; 2012 Feb; 11(2):340-9. PubMed ID: 22147747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A CAIX Dual-Targeting Small-Molecule Probe for Noninvasive Imaging of ccRCC.
    He C; Liu F; Tao J; Wang Z; Liu J; Liu S; Xu X; Li L; Wang F; Yang X; Zhu H; Yang Z
    Mol Pharm; 2024 Jul; 21(7):3383-3394. PubMed ID: 38831541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbonic anhydrase IX promotes tumor growth and necrosis in vivo and inhibition enhances anti-VEGF therapy.
    McIntyre A; Patiar S; Wigfield S; Li JL; Ledaki I; Turley H; Leek R; Snell C; Gatter K; Sly WS; Vaughan-Jones RD; Swietach P; Harris AL
    Clin Cancer Res; 2012 Jun; 18(11):3100-11. PubMed ID: 22498007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel
    Guan SS; Wu CT; Liao TZ; Lin KL; Peng CL; Shih YH; Weng MF; Chen CT; Yeh CH; Wang YC; Liu SH
    Eur J Pharm Biopharm; 2021 Nov; 168():38-52. PubMed ID: 34450241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PET Imaging of Carbonic Anhydrase IX Expression of HT-29 Tumor Xenograft Mice with (68)Ga-Labeled Benzenesulfonamides.
    Lau J; Zhang Z; Jenni S; Kuo HT; Liu Z; Vullo D; Supuran CT; Lin KS; Bénard F
    Mol Pharm; 2016 Mar; 13(3):1137-46. PubMed ID: 26866675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypoxia-Targeting Fluorescent Nanobodies for Optical Molecular Imaging of Pre-Invasive Breast Cancer.
    van Brussel AS; Adams A; Oliveira S; Dorresteijn B; El Khattabi M; Vermeulen JF; van der Wall E; Mali WP; Derksen PW; van Diest PJ; van Bergen En Henegouwen PM
    Mol Imaging Biol; 2016 Aug; 18(4):535-44. PubMed ID: 26589824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Novel ¹¹¹In-Labeled Anti-Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer.
    Chatalic KL; Veldhoven-Zweistra J; Bolkestein M; Hoeben S; Koning GA; Boerman OC; de Jong M; van Weerden WM
    J Nucl Med; 2015 Jul; 56(7):1094-9. PubMed ID: 25977460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimization of IGF-1R SPECT/CT imaging using 111In-labeled F(ab')2 and Fab fragments of the monoclonal antibody R1507.
    Heskamp S; van Laarhoven HW; Molkenboer-Kuenen JD; Bouwman WH; van der Graaf WT; Oyen WJ; Boerman OC
    Mol Pharm; 2012 Aug; 9(8):2314-21. PubMed ID: 22747077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fusion of hIgG1-Fc to 111In-anti-amyloid single domain antibody fragment VHH-pa2H prolongs blood residential time in APP/PS1 mice but does not increase brain uptake.
    Rotman M; Welling MM; van den Boogaard ML; Moursel LG; van der Graaf LM; van Buchem MA; van der Maarel SM; van der Weerd L
    Nucl Med Biol; 2015 Aug; 42(8):695-702. PubMed ID: 25960433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors.
    Lou Y; McDonald PC; Oloumi A; Chia S; Ostlund C; Ahmadi A; Kyle A; Auf dem Keller U; Leung S; Huntsman D; Clarke B; Sutherland BW; Waterhouse D; Bally M; Roskelley C; Overall CM; Minchinton A; Pacchiano F; Carta F; Scozzafava A; Touisni N; Winum JY; Supuran CT; Dedhar S
    Cancer Res; 2011 May; 71(9):3364-76. PubMed ID: 21415165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biodistribution and pharmacokinetics of 125I-labeled monoclonal antibody M75 specific for carbonic anhydrase IX, an intrinsic marker of hypoxia, in nude mice xenografted with human colorectal carcinoma.
    Chrastina A; Závada J; Parkkila S; Kaluz S; Kaluzová M; Rajcáni J; Pastorek J; Pastoreková S
    Int J Cancer; 2003 Jul; 105(6):873-81. PubMed ID: 12767076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Picomolar fluorescent probes for compound affinity determination to carbonic anhydrase IX expressed in live cancer cells.
    Matulienė J; Žvinys G; Petrauskas V; Kvietkauskaitė A; Zakšauskas A; Shubin K; Zubrienė A; Baranauskienė L; Kačenauskaitė L; Kopanchuk S; Veiksina S; Paketurytė-Latvė V; Smirnovienė J; Juozapaitienė V; Mickevičiūtė A; Michailovienė V; Jachno J; Stravinskienė D; Sližienė A; Petrošiūtė A; Becker HM; Kazokaitė-Adomaitienė J; Yaromina A; Čapkauskaitė E; Rinken A; Dudutienė V; Dubois LJ; Matulis D
    Sci Rep; 2022 Oct; 12(1):17644. PubMed ID: 36271018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and comparison of three
    Hu G; Zhu W; Liu Y; Wang Y; Zhang Z; Zhu S; Duan W; Zhou P; Fu C; Li F; Huo L
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2634-2644. PubMed ID: 35347439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.